BioCatalyst

INZ-701 — catalyst calendar

2 verified catalyst event(s) referencing INZ-701, each linked to its official source. Verified as of 2026-09-20.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-10 (month)
in 11d
ESTIMATED
 READOUT
ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency
Phase 2 · Gene Mutations, Pseudoxanthoma Elasticum
 Inozyme Pharma INZ-701 ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
2026-10-14
in 24d
ESTIMATED
 READOUT
ENERGY 2: Evaluation of the Efficacy and Safety of INZ-701 in Infants With ENPP1
Phase 3 · Ectonucleotide Pyrophosphatase/phosphodiesterase1 Deficiency, Autosomal Recessive Hypophosphatemic Rickets
 Inozyme Pharma INZ-701 ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.